mevalonolactone has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, YY; Chen, MH; Ge, MX; He, HW; Li, Y; Li, YM; Lu, ZN; Niu, WX; Zhang, N | 1 |
| Celsi, F; Crovella, S; Gratton, R; Tricarico, PM | 1 |
2 other study(ies) available for mevalonolactone and Inflammation
| Article | Year |
|---|---|
Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
Topics: Animals; Fibrosis; Humans; Inflammasomes; Inflammation; Liver; Liver Cirrhosis; Mevalonic Acid; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Rats | 2022 |
Prolonged treatment with mevalonolactone induces oxidative stress response with reactive oxygen species production, mitochondrial depolarization and inflammation in human glioblastoma U-87 MG cells.
Topics: Glioblastoma; Humans; Inflammation; Mevalonate Kinase Deficiency; Mevalonic Acid; Oxidative Stress; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Reactive Oxygen Species | 2018 |